Geadkaew-Krenc Amornrat, Krenc Dawid, Thanongsaksrikul Jeeraphong, Grams Rudi, Phadungsil Wansika, Glab-Ampai Kittirat, Chantree Pathanin, Martviset Pongsakorn
Graduate Program in Biomedical Sciences, Faculty of Allied Health Sciences, Thammasat University, Pathumthani 12120, Thailand.
Thammasat University Research Unit in Parasitic Diseases, Pathumthani 12120, Thailand.
Trop Med Infect Dis. 2023 Mar 6;8(3):160. doi: 10.3390/tropicalmed8030160.
(1) Background: is a significant health problem in the Mekong subregion of Southeast Asia, causing aggressive cholangiocarcinoma. Current diagnostic procedures do not cover early diagnosis and low infection. Hence, an effective diagnostic tool is still required. Immunodiagnosis seems promising, but attempts to generate monoclonal antibodies have not yet been successful. This study aims to develop a single-chain variable antibody fragment (scFv) against Rhophilin-associated tail protein 1-like (ROPN1L), the sperm-specific antigen of adult , which has not been reported elsewhere. (2) Methods: The target epitope for phage screening was L3-Q13 of OvROPN1L, which showed the highest antigenicity to human opisthorchiasis analyzed in a previous study. This peptide was commercially synthesized and used for phage library screening. The isolated phage was produced in a bacterial expression system and tested for specificity in vitro and in silico. (3) Results: One of fourteen phages, named scFv anti-OvROPN1L-CL19, significantly bound to rOvROPN1L compared with non-infected hamster fecal extracts. This phage clone was successfully produced and purified using Ni-NTA chromatography. Indirect ELISA demonstrated that scFv anti-OvROPN1L-CL19 has a high reactivity with -infected hamster fecal extracts (12 wpi, 6) in comparison with non-infected hamster fecal extracts (0 wpi, = 6), while the polyclonal rOvROPN1L antibodies did not show such a difference. Molecular modeling and docking confirmed our in vitro findings. (4) Conclusion: scFv anti-OvROPN1L-CL19 could be used as an effective material for developing -immunodiagnostic procedures in the future.
(1)背景:在东南亚湄公河次区域,[疾病名称未给出]是一个严重的健康问题,可引发侵袭性胆管癌。目前的诊断程序无法实现早期诊断和低感染检测。因此,仍需要一种有效的诊断工具。免疫诊断似乎很有前景,但生成单克隆抗体的尝试尚未成功。本研究旨在开发一种针对类亲嗜素相关尾蛋白1(ROPN1L)的单链可变抗体片段(scFv),ROPN1L是[疾病名称未给出]成虫的精子特异性抗原,此前未见其他报道。(2)方法:用于噬菌体筛选的目标表位是OvROPN1L的L3 - Q13,在先前的一项研究中,该表位对人类华支睾吸虫病显示出最高的抗原性。该肽段通过商业合成获得,并用于噬菌体文库筛选。分离得到的噬菌体在细菌表达系统中产生,并进行体外和计算机模拟的特异性测试。(3)结果:14个噬菌体中的一个,命名为scFv抗 - OvROPN1L - CL19,与未感染仓鼠的粪便提取物相比,与重组OvROPN1L(rOvROPN1L)有显著结合。该噬菌体克隆成功产生并使用镍 - 氮三乙酸(Ni - NTA)色谱法纯化。间接酶联免疫吸附测定(ELISA)表明,与未感染仓鼠的粪便提取物(感染后0周,n = 6)相比,scFv抗 - OvROPN1L - CL19与感染[疾病名称未给出]的仓鼠粪便提取物(感染后12周,n = 6)具有高反应性,而多克隆rOvROPN1L抗体未显示出这种差异。分子建模和对接证实了我们的体外研究结果。(4)结论:scFv抗 - OvROPN1L - CL19未来可作为开发[疾病名称未给出]免疫诊断程序的有效材料。